由于利润下降和 2024 年前景谨慎，瑞士制药公司罗氏在产品开发领域裁员 345 人。 Swiss pharmaceutical company Roche cuts 345 jobs in product development due to lower profits and cautious 2024 outlook.

瑞士制药公司罗氏 (Roche) 因利润下降和对 2024 年前景持谨慎态度，将裁员 345 人。 Swiss pharmaceutical company Roche is cutting 345 jobs in response to lower profits and a cautious outlook for 2024. 裁员将影响产品开发领域，约占该领域劳动力的 6%。 The job cuts will affect the product development area, representing around 6% of the workforce in that sector. 罗氏告诉路透社，虽然大部分受影响的工作岗位都在瑞士，但受影响的工作岗位数量将少于 345 人。 While the majority of the affected jobs are in Switzerland, Roche told Reuters the number of jobs affected would be less than 345 people. 该公司预计 2024 年员工总数将保持稳定。 The company expects its total workforce to remain stable in 2024.